Literature DB >> 3494996

Differential regulation of colony-stimulating factors and interleukin 2 production by cyclosporin A.

M Bickel, H Tsuda, P Amstad, V Evequoz, S E Mergenhagen, S M Wahl, D H Pluznik.   

Abstract

Stimulation of T lymphocytes with mitogens or antigens is followed by proliferation and lymphokine production. Although cyclosporin A (CsA), an immunosuppressive drug, has been shown to inhibit the production of certain lymphokines, including interleukin 2 (IL-2), interleukin 3 (IL-3), and gamma-interferon, its effect on the production of granulocyte/macrophage colony-stimulating factor (GM-CSF) has not been evaluated. In the current study, concanavalin A (Con A)-stimulated murine spleen cells secreted GM-CSF, IL-3, and IL-2, and in the presence of CsA (0.1-1.0 micrograms/ml), IL-2 and IL-3 activities were inhibited. In contrast, significant activity was detected when the CsA-treated culture supernatants were assayed on a cell line that is dependent on GM-CSF and/or IL-3. Similar CsA-resistant activity was observed when the EL-4 thymoma cells were stimulated with a phorbol ester [phorbol 12-myristate 13-acetate (PMA)] in the presence of CsA. The activity resistant to CsA was identified as GM-CSF by the ability of specific antibodies against murine recombinant GM-CSF to neutralize its activity. These findings indicate that GM-CSF, in contrast to IL-2 and IL-3, was not inhibited by CsA. In additional experiments, transfer blot of poly(A)+ RNA isolated from PMA-induced EL-4 cells in the presence or the absence of CsA was hybridized with GM-CSF and IL-2 cDNA probes. Expression of the GM-CSF gene in EL-4 cells was detected independent of CsA, whereas CsA inhibited the expression of the IL-2 gene. The present data show that production of IL-2 and IL-3, but not that of GM-CSF, is inhibited by CsA and suggest a differential control mechanism for lymphokine synthesis in T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494996      PMCID: PMC304851          DOI: 10.1073/pnas.84.10.3274

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor.

Authors:  N M Gough; J Gough; D Metcalf; A Kelso; D Grail; N A Nicola; A W Burgess; A R Dunn
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

2.  Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues.

Authors:  M Piechaczyk; J M Blanchard; L Marty; C Dani; F Panabieres; S El Sabouty; P Fort; P Jeanteur
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

3.  Biology and biochemistry of T cell-derived lymphokines. I. The coordinate synthesis of interleukin 2 and colony-stimulating factors in a murine T cell lymphoma.

Authors:  J D Watson
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

4.  Analysis of cloned T cell function. II. Differential blockade of various cloned T cell functions by cyclosporine.

Authors:  C G Orosz; D C Roopenian; M B Widmer; F H Bach
Journal:  Transplantation       Date:  1983-12       Impact factor: 4.939

5.  Induction of interleukin 2 messenger RNA inhibited by cyclosporin A.

Authors:  J F Elliott; Y Lin; S B Mizel; R C Bleackley; D G Harnish; V Paetkau
Journal:  Science       Date:  1984-12-21       Impact factor: 47.728

6.  Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.

Authors:  M Krönke; W J Leonard; J M Depper; S K Arya; F Wong-Staal; R C Gallo; T A Waldmann; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.

Authors:  A Kelso; A L Glasebrook
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  Monoclonal cytolytic T-cell lines.

Authors:  P E Baker; S Gillis; K A Smith
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

10.  Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A.

Authors:  A Granelli-Piperno; K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  11 in total

1.  Immunosuppression with cyclosporin A alters the thymic microenvironment.

Authors:  M Kanariou; R Huby; H Ladyman; M Colic; G Sivolapenko; I Lampert; M Ritter
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons.

Authors:  W E Pullman; W F Doe
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

3.  Effects of a novel immunosuppressive agent, FK506, on human B cell activation.

Authors:  N Suzuki; T Sakane; T Tsunematsu
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

4.  Identification of multiple cis-elements and trans-acting factors involved in the induced expression of human IL-2 gene.

Authors:  H Shibuya; T Taniguchi
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

Review 5.  Regulation of colony-stimulating factor production by normal and leukemic human cells.

Authors:  T J Ernst; J D Griffin
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

6.  Regulated production of a pleiotropic cytokine-platelet-derived growth factor--by differentiating erythroid cells in vitro and in vivo.

Authors:  J C Keutzer; A J Sytkowski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

7.  Different inhibitory actions of cyclosporine A and cyclosporine A-acetate on lipopolysaccharide-, interleukin 1-, 1,25 dihydroxyvitamin D3- and parathyroid hormone-stimulated calcium and lysosomal enzyme release from mouse calvaria in vitro.

Authors:  H Tullberg-Reinert; A F Hefti
Journal:  Agents Actions       Date:  1991-03

8.  T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.

Authors:  J P Sypek; D J Wyler
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

9.  The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.

Authors:  P S Mattila; K S Ullman; S Fiering; E A Emmel; M McCutcheon; G R Crabtree; L A Herzenberg
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  Immunosuppression by immunoglobulin deaggregation is not effective in reducing the anti-xenogeneic immunoglobulin response: experimental and clinical studies.

Authors:  G B Sivolapenko; M Kanariou; R J Edwards; A A Epenetos; M A Ritter
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.